Evidence map›Paper›PMID 31236121›Full record

ArticleCellular & molecular biology letters2019

Mesenchymal stem cells decrease blood-brain barrier permeability in rats with severe acute pancreatitis.

Ronggui Lin, Ming Li, Meiqin Luo, Tianhong Teng, Yu Pan, Heguang Huang

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cellular & molecular biology letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Treating Metastatic Brain Cancers With Stem Cells.Frontiers in molecular neuroscience · 2021
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ronggui Lin *1Department of General surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian 350001 People's Republic of China.
Ming Li *2Department of Histology and Embryology, Hunan University of Medicine, Huaihua, Hunan China.
Meiqin Luo3Department of Orthopedics, Fujian Medical University Union Hospital, Fuzhou, Fujian China.
Tianhong Teng1Department of General surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian 350001 People's Republic of China.
Yu Pan1Department of General surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian 350001 People's Republic of China.
Heguang Huang1Department of General surgery, Fujian Medical University Union Hospital, 29 Xinquan Road, Fuzhou, Fujian 350001 People's Republic of China.
Fujian Medical University · CNHunan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImpairment of the blood-brain barrier (BBB) could result in secondary cerebral edema and life-threatening pancreatic encephalopathy in patients with severe acute pancreatitis (SAP). Mesenchymal stem cells (MSCs) have been widely adopted in clinical research because of their pleiotropic functions. The aim of this study was to investigate the impact of MSCs on BBB permeability in SAP and the potential mechanisms driving these effects.

methodsSprague-Dawley rats were randomly assigned to the control, SAP and SAP+MSCs groups. Pancreatic impairment was assessed. The serum levels of amylase, TNF-α and IL-10, expression levels of claudin-5, Bax, Bcl-2 and MMP-9, and the BBB permeability were measured. Endothelial cell apoptosis was evaluated.

resultsSAP rats showed BBB impairment with increased permeability and secondary cerebral edema, which was confirmed using the Evans blue assay and the calculation of the brain dry/wet ratio. Treatment with MSCs decreased the serum levels of amylase and TNF-α, increased the serum levels of IL-10, attenuated the apoptosis of brain microvascular endothelial cells, upregulated claudin-5 expression and downregulated MMP-9 expression. This treatment attenuated the increased BBB permeability in SAP rats.

conclusionsMSCs attenuated the impairment of the BBB and decreased its permeability, producing protective effects in SAP rats.

Indexed as

Mesenchymal Stem Cell TransplantationAcute DiseaseAmylasesAnimalsApoptosisBlood-Brain BarrierClaudin-5Disease Models, AnimalEndothelial CellsInterleukin-10MaleMatrix Metalloproteinase 9PancreatitisPermeabilityRatsRats, Sprague-DawleyAmylasesClaudin-5Interleukin-10Matrix Metalloproteinase 9Tumor Necrosis Factor-alphaBlood–brain barrierEndothelial cellInflammatory responseMesenchymal stem cellSevere acute pancreatitis

Identifiers

PMID31236121
PMCPMC6580617
OpenAlexW2949651547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.